No Data
No Data
OS Therapies Shares Surge After FDA Agrees to Meeting on Bone Cancer Therapy
OS Therapies Granted FDA Meeting Request To Gain Alignment On Surrogate Endpoint To Support Breakthrough Therapy Designation & Accelerated Approval Of OST-HER2 In Prevention Of Recurrence Of Fully Resected, Lung Metastatic Osteosarcoma
Express News | Os Therapies Inc - Ost-Her2 Eligible for Priority Review Voucher if Approved by Sept 2026
Express News | Os Therapies Inc - FDA Response Expected by Mid-June 2025
With Young Adult Cancer on the Rise, New Therapies Spark Investor Buzz
Express News | Os Therapies - Treatment With Ost-Her2 Was Found to Be Safe and Well Tolerated
d4r : will instant rise?
健谈的克利夫兰 :![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)